Home- versus office-based buprenorphine inductions for opioid-dependent patients

Journal of Substance Abuse Treatment

Volumn 38, Issue 2, 2010, Pages 153-159

  Sohler, Nancy L ^a,b   Li, Xuan ^b   Kunins, Hillary V ^b   Sacajiu, Galit ^b   Giovanniello, Angela ^b   Whitley, Susan ^c   Cunningham, Chinazo O ^b  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

Buprenorphine induction; Buprenorphine treatment; Community health center; Opioid dependence; Primary care

Indexed keywords

ADULT; AMBULATORY CARE FACILITIES; BUPRENORPHINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PATIENT SELECTION; PRIMARY HEALTH CARE; SELF ADMINISTRATION; TREATMENT OUTCOME;

EID: 74249083192     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2009.08.001     Document Type: Article

References (23)

1. Alford D.P., LaBelle C.T., Richardson J.M., O'Connell J.J., Hohl C.A., Cheng D.M., et al. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. Journal of General Internal Medicine 22 (2007) 171-176
2. Bodenheimer T., Lorig K., Holman H., and Grumbach K. Patient self-management of chronic disease in primary care. JAMA 288 (2002) 2469-2475
3. Center for Substance Abuse Treatment. Clinical guidelines for the uses of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) series 40. DHHS Publication No. (SMA) 04-3939 (2004) Rockville, MD
4. Cunningham C., Giovanniello A., Sacajiu G., Whitley S., Mund P., Beil R., et al. Buprenorphine treatment in an urban community health center: What to expect. Family Medicine 40 (2008) 500-506
5. Drug Addiction Treatment Act of 2000. Public Law 106-210.
6. Fiellin D.A., Pantalon M.V., Pakes J.P., O'Connor P.G., Chawarski M., and Schottenfeld R.S. Treatment of heroin dependence with buprenorphine in primary care. American Journal of Drug and Alcohol Abuse 28 (2002) 231-241
7. Frank B. An overview of heroin trends in New York City: Past, present and future. Mt. Sinai Journal of Medicine 67 (2000) 340-346
8. Hibbard J.H., and Cunningham P.J. How engaged are consumers in their health and health care, and why does it matter?. Research Briefs 8 (2008) 1-9
9. Lee J.D., Grossman E., DiRocco D., and Gourevitch M.N. Home buprenorphine/naloxone induction in primary care. Journal of General Internal Medicine 24 (2008) 226-232
10. Lorig K.R., Ritter P., Stewart A.L., Sobel D.S., Brown Jr. B.W., Bandura A., et al. Chronic disease self-management program: 2-Year health status and health care utilization outcomes. Medical Care 39 (2001) 1217-1223
11. Lorig K.R., Sobel D.S., and Stewart A.L. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: A randomized trial. Medical Care 37 (1999) 5-14
12. McEvoy P., and Barnes P. Using the chronic care model to tackle depression among older adults who have long-term physical conditions. Journal of Psychiatric Mental Health Nursing 14 (2007) 233-238
13. Mintzer I.L., Eisenberg M., Terra M., MacVane C., Himmelstein D.U., and Woolhandler S. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Annals of Family Medicine 5 (2007) 146-150
14. Mosen D.M., Schmittdiel J., Hibbard J., Sobel D., Remmers C., and Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions?. Journal of Ambulatory Care Management 30 (2007) 21-29
15. New York City Department of Health and Mental Hygiene. (2008). Buprenorphine Initiative. Accessed on 2/12/08 at http://home2.nyc.gov/html/doh/downloads/pdf/basas/presentation-buprenorphine.pdf
16. O'Connor P.G., Oliveto A.H., Shi J.M., Triffleman E.G., Carroll K.M., Kosten T.R., et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. American Journal of Medicine 105 (1998) 100-105
17. Stein M.D., Cioe P., and Friedmann P.D. Buprenorphine retention in primary care. Journal of General Internal Medicine 20 (2005) 1038-1041
18. Street Jr. R.L., Gordon H.S., Ward M.M., Krupat E., and Kravitz R.L. Patient participation in medical consultations: Why some patients are more involved than others. Medical Care 43 (2005) 960-999
19. Sullivan L.E., Barry D., Moore B.A., Chawarski M.C., Tetrault J.M., Pantalon M.V., et al. A trial of integrated buprenorphine/naloxone and HIV clinical care. Clinical Infectious Diseases 43 (2006) S184-S190
20. Tobias C., Cunningham W.E., Cunningham C.O., and Pounds M.B. AIDS Patient Care & STDs 21 (2007) S3-S8
21. Wagner E.H. Chronic disease management: What will it take to improve care for chronic illness?. Effective Clinical Practice 1 (1998) 2-4
22. Wagner E.H., Austin B.R., Davis C., Hindmarsh M., Schaefer J., and Bonomi A. Improving chronic illness care translating evidence into action. Health Affairs 20 (2001) 64-78
23. Watkins K., Pincus H.A., Tanielian T.L., and Lloyd J. Using the chronic care model to improve treatment of alcohol use disorders in primary care settings. Journal of Studies on Alcohol 64 (2003) 209-218